# Safety and Efficacy of a Probiotic Supplement in IBS-D

> **NCT05754177** · NA · COMPLETED · sponsor: **The Archer-Daniels-Midland Company** · enrollment: 46 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Diarrhea
- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05754177
- **Lead sponsor:** The Archer-Daniels-Midland Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-06
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754177, "Safety and Efficacy of a Probiotic Supplement in IBS-D". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05754177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*